US EditionFighting Prostate Cancer with Cellular "Hinges" Is the New Trail of American Researchers
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
Prostate cancer has long been resistant to conventional immune treatments. Yet, a team of American researchers has just crossed a decisive course in this area. By modifying a single amino acid in the receptor of certain immune cells, they have succeeded in transforming naturally too weak defences into machines capable of stopping tumour growth. The study opens a serious prospect for more effective and better tolerated future treatments.
Researchers at UCLA and Stanford Medicine, in collaboration with scientists at the University of Utah and Columbia University, all centers in the United States, have designed a new class of superpower T cells that are stronger, more durable and more accurate in eliminating prostate cancer cells, precisely adjusting the way they interact physically with tumor cells. This approach, described in Science magazine, represents an important step toward…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
